© 2017 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Reyataz

Gilead Files For FDA Approval of Integrase Inhibitor–Based HIV Regimen

The single-tablet regimen includes the experimental bictegravir plus the contents of Descovy (emtricitabine/tenofovir alafenamide).

Reyataz

Combo Nanotherapy Greatly Lowers HIV Levels in Mice

Combo treatment with fine-particle formulations of Reyataz and Norvir, plus an immune-dampener drug, greatly reduced HIV levels in mice.

Another Two-Drug HIV Regimen Shows Promise

A two-drug regimen of Norvir (ritonavir)–boosted Reyataz (atazanavir) and Epivir (lamivudine) treats HIV as well or better tha...

Bristol-Myers Squibb's HIV Maturation Inhibitor Shows Promise

Research of Bristol-Myers Squibb's BMS-955176, an HIV maturation inhibitor, has shown the antiretroviral is potent and well-tolerated.

Updated Tenofovir Is Safer for Bones and Kidneys

An updated version of Viread (tenofovir) offers slightly better viral suppression and improves indicators of kidney and bone health...

BMS's Maturation Inhibitor Shows Promise

Bristol-Myers Squibb's investigational next-generation maturation inhibitor BMS-955176 demonstrated good activity against HIV when paired...

BMS HIV Attachment Inhibitor Gets FDA Breakthrough Nod

The FDA has granted a breakthrough designation to Bristol-Myers Squibb's investigational HIV attachment inhibitor BMS-663068.

Certain HIV Meds Raise Risk of Heart Trouble

Various HIV antiretrovirals are linked to a raised risk of cardiovascular problems, although the overall risk of such an outcome is still low.

HIV Treatment Guidelines Nix Atripla as First-Line Therapy

A revision of U.S. HIV treatment guidelines has removed Atripla (efavirenz/tenofovir/emtricitabine) from the priority list of first-line antir...

Isentress and Protease Inhibitors Lead to Similar Fat Gains

People with HIV who start treatment with Truvada post similar fat gains whether they pair the tablet with Isentress or protease inhibitors.

HIV May Increase Body Fat

People with HIV may experience body fat gains as a consequence of the virus rather than antiretrovirals.

Several HIV Meds Steadily Raise Kidney Disease Risk Over Time

People with HIV who take Viread, Norvir, Reyataz or Norvir-boosted Kaletra are at increasing risk of kidney disease over time.

Attachment Inhibitor from BMS, A New Class of HIV Drug, Shows Promise

Given to treatment-experienced people with HIV, the attachment inhibitor BMS-663068 (fostemsavir) demonstrated potentcy in the range of...

FDA Approves Evotaz (Atazanavir/Cobicistat) to Treat HIV

The FDA has approved the combination tablet Evotaz (atazanavir/cobicistat) to be used in combination with other antiretrovirals to treat...

HIV Meds Early in Pregnancy Linked to Low Risk of Birth Defects

Pregnant women who take antiretrovirals (ARVs) to treat HIV early in their pregnancies appear to have a low risk of birth defects in their inf...
Advertisement